Hanmi Pharmaceutical Shares Surge on $2.31 Billion Genentech Licensing Deal

Hanmi Pharmaceutical's shares experienced a significant jump following the announcement of a $2.31 billion licensing agreement with Genentech, a major biotechnology company.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

morningstarSwedish3d ago

Hanmi Pharmaceutical Shares Jump After Signing $2.31 Billion Licensing Deal With Genentech - Morningstar

Hanmi Pharmaceutical Shares Jump After Signing $2.31 Billion Licensing Deal With Genentech Morningstar

Read full article →

PERSPECTA

PERSPECTA

Hanmi Pharmaceutical Shares Surge on $2.31 Billion Genentech Licensing Deal

Sources

Hanmi Pharmaceutical Shares Jump After Signing $2.31 Billion Licensing Deal With Genentech - Morningstar

Related Stories

Samsung Biologics Launches 3 Trillion Won Rights Offering for Global Expansion

Markets Brace for Clarity as Fed Chair Warsh Prepares Jackson Hole Address

US Nears Deal to Secure Long-Term Stake in Venezuelan Oil Reserves

Cathie Wood’s ARK Invest Sells AMD and Tempus AI Stakes

PERSPECTA